MORGAN STANLEY - TRACON PHARMACEUTICALS INC ownership

TRACON PHARMACEUTICALS INC's ticker is TCON and the CUSIP is 89237H209. A total of 47 filers reported holding TRACON PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.47 and the average weighting 0.1%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of TRACON PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$10
-99.8%
7
-99.6%
0.00%
Q1 2022$5,000
+25.0%
1,940
+38.1%
0.00%
Q4 2021$4,000
-95.8%
1,405
-94.3%
0.00%
Q3 2021$96,000
+28.0%
24,704
+114.3%
0.00%
Q2 2021$75,000
-62.1%
11,527
-52.0%
0.00%
Q1 2021$198,000
-90.7%
23,998
-86.8%
0.00%
Q4 2020$2,125,000
+106150.0%
181,561
+16212.8%
0.00%
Q2 2020$2,0000.0%1,1130.0%0.00%
Q1 2020$2,0001,1130.00%
Other shareholders
TRACON PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Opaleye Management Inc. 2,518,371$9,746,0001.82%
Altium Capital Management LP 785,341$3,039,0000.80%
Ikarian Capital, LLC 2,691,110$10,415,0000.73%
Telemetry Investments, L.L.C. 130,500$505,0000.68%
Psagot Value Holdings Ltd. 143,591$556,0000.10%
Psagot Value Holdings Ltd. / (Israel) 143,591$556,0000.10%
ACT CAPITAL MANAGEMENT, LLC 28,500$110,0000.06%
X-Square Capital, LLC 17,973$70,0000.04%
GSA CAPITAL PARTNERS LLP 85,993$333,0000.03%
BOOTHBAY FUND MANAGEMENT, LLC 268,301$1,038,0000.03%
View complete list of TRACON PHARMACEUTICALS INC shareholders